The Company's goal is to develop, manufacture and market a complete line of indwelling catheters that will significantly reduce the incidence of infection, while providing clear clinical and economical advantages.
Innoventions is developing a device for the treatment of incontinence, over active bladder (OAB), and superficial bladder cancer (depending on the drug inserted to the INDB).